Scholarlink

<p>Although regeneration of the dentin-pulp complex is a key goal in endodontic therapy, pulpal inflammation can impede effective tissue repair and sustained healing. Recent studies suggest that proteasome inhibitors can modulate key cellular processes involved in tissue regeneration. MG132 (carbobenzoxy-Leu-Leu-leucinal) is a reversible proteasome inhibitor used in experimental settings to study these mechanisms, although its efficacy in <i>in vivo</i> models of dental tissue regeneration remains unclear. In this study, we investigated the effects of MG132 in modulating inflammation and regenerating dentin using a murine pulp exposure model. Involved signaling pathways were examined using <i>in vitro-</i>cultivated human dental pulp stem cells (hDPSCs). MG132 was then locally administered into exposed pulp cavities. Inflammation, cellular differentiation, and hard tissue formation were assessed using histological staining, immunohistochemistry, and micro-computed tomography, respectively. Following MG132 treatment of hDPSCs, RT-qPCR revealed the elevated expression of Wnt signaling-related molecules involved in dentin formation. At day 5 of treatment, MG132 significantly reduced the expression of inflammatory markers, including myeloperoxidase, F4/80, nuclear factor kappa B, and tumor necrosis factor-alpha, indicating attenuation of early excessive inflammatory responses. In addition, treatment enhanced odontoblast differentiation and mineralization, as evidenced by the upregulated expression of Nestin, collagen type I alpha-1, transforming growth factor beta 1, runt-related transcription factor 2, osteopontin, and osteocalcin. Moreover, at 42&#xa0;days, MG132-treated samples exhibited distinct dentin bridge formation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

MG132 facilitates dentin regeneration by modulating inflammation and odontoblast differentiation

  • 期刊论文

  • 发表日期：

    2026年2月19日

查看全文
  • Bandana Rana,
  • Elina Pokharel,
  • Je-Hee Jang,
  • Jae-Hee Lee,
  • Hitoshi Yamamoto,
  • Ji-Youn Kim,
  • Eui-Kyun Park,
  • Wern-Joo Sohn,
  • Seo-Young An,
  • Chang-Hyeon An,
  • Young-Eun Kwon,
  • Youngkyun Lee,
  • Jae-Kwang Jung,
  • Jung-Hong Ha,
  • Jae-Young Kim

摘要

Although regeneration of the dentin-pulp complex is a key goal in endodontic therapy, pulpal inflammation can impede effective tissue repair and sustained healing. Recent studies suggest that proteasome inhibitors can modulate key cellular processes involved in tissue regeneration. MG132 (carbobenzoxy-Leu-Leu-leucinal) is a reversible proteasome inhibitor used in experimental settings to study these mechanisms, although its efficacy in in vivo models of dental tissue regeneration remains unclear. In this study, we investigated the effects of MG132 in modulating inflammation and regenerating dentin using a murine pulp exposure model. Involved signaling pathways were examined using in vitro-cultivated human dental pulp stem cells (hDPSCs). MG132 was then locally administered into exposed pulp cavities. Inflammation, cellular differentiation, and hard tissue formation were assessed using histological staining, immunohistochemistry, and micro-computed tomography, respectively. Following MG132 treatment of hDPSCs, RT-qPCR revealed the elevated expression of Wnt signaling-related molecules involved in dentin formation. At day 5 of treatment, MG132 significantly reduced the expression of inflammatory markers, including myeloperoxidase, F4/80, nuclear factor kappa B, and tumor necrosis factor-alpha, indicating attenuation of early excessive inflammatory responses. In addition, treatment enhanced odontoblast differentiation and mineralization, as evidenced by the upregulated expression of Nestin, collagen type I alpha-1, transforming growth factor beta 1, runt-related transcription factor 2, osteopontin, and osteocalcin. Moreover, at 42 days, MG132-treated samples exhibited distinct dentin bridge formation.